Booster Shots

Oddities, musings and news from the health world

« Previous Post | Booster Shots Home | Next Post »

FDA OKs marketing Plan B to 17-year-olds

April 22, 2009 |  3:54 pm

The Food and Drug administration announced today that it has notified the maker of Plan B, the morning-after pill, permitting it to market the drug to 17-year-olds without a prescription. The move follows a March ruling by a federal judge that the FDA's earlier decision requiring those younger than 18 to consult with a doctor was not justified on safety grounds.

Here's a recent article on the Plan B issue. And here's more info plus what others are saying about this latest move:

The FDA statement and a page detailing the drug's regulatory history;

Center for Reproductive Rights, which sued the FDA on its delay to grant over-the-counter access of Plan B;

Family Research Council, which opposes the judge's ruling;

An Associated Press article on the FDA's latest move;

Plan B website.

-- Rosie Mestel





Comments 

Advertisement










Video